Authors and Affiliates
Esteban Arrieta-Bolaños1, Pietro Crivello1, Maximilian Metzing1, Thuja Meurer1, Müberra Ahci1, Julie Rytlewski2, Marissa Vignali2, Erik Yusko2, Peter van Balen3, Peter A. Horn4, J. H. Frederik Falkenburg3, and Katharina Fleischhauer1,5
1Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany, 2Adaptive Biotechnologies, Seattle, WA, United States, 3Department of Hematology, Leiden University Medical Center, Leiden, Netherlands, 4Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany, 5German Cancer Consortium (DKTK), Heidelberg, Germany
Abstract Reference
